Titre:
  • Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
Auteur:Tomiak, E; Piccart-Gebhart, Martine; Kerger, Joseph; Lips, S; Awada, Ahmad; De Valeriola, Dominique; Ravoet, Christophe; Lossignol, Dominique; Sculier, Jean-Paul; Auzannet, V
Informations sur la publication:Journal of clinical oncology, 12, 7, page (1458-1467)
Statut de publication:Publié, 1994-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Agents, Phytogenic -- adverse effects
Antineoplastic Agents, Phytogenic -- pharmacokinetics
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms -- drug therapy
Paclitaxel -- administration & dosage
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Paclitaxel -- pharmacokinetics
Taxoids
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase I
Controlled Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:pmid/7912725